LDLR Gene Mutation p.Asp360His and Familial Hypercholesterolemia in a Mexican Community-Reference-Cited by-同舟云学术

LDLR Gene Mutation p.Asp360His and Familial Hypercholesterolemia in a Mexican Community

Published:2020-02 Issue:2 Volume:51 Page:153-159
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Hernández Flores Teresita De Jesús,González García Juan Ramón,Sánchez López Yoaly Josefina,Vázquez Cárdenas Norma Alejandra,Colima Fausto Ana Gabriela,Rodríguez Preciado Sergio Yair,Magaña Torres María Teresa

Funder

Consejo Nacional de Ciencia y Tecnología

Fundación IMSS

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Update on familial hypercholesterolemia: diagnosis, cardiovascular risk, and novel therapeutics;Lee;Endocrinol Metab,2017

2. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

3. National Lipid Association Annual Summary of Clinical Lipidology 2016;Bays;J Clin Lipidol,2016

4. Value of the definition of severe familial hypercholesterolemia for stratification of heterozygous patients;Pérez-Calahorra;Am J Cardiol,2017

5. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment;Farnier;Atheroscler Suppl,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico;Archives of Medical Research;2024-04

2. Does Genotype Affect the Efficacy of PCSK9 Inhibitors in the Treatment of Familial Hypercholesterolemia?;Cardiovascular Drugs and Therapy;2023-08-23